LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

被引:94
|
作者
Wei, Shuquan [1 ]
Wang, Kangwei [2 ]
Huang, Xiaomei [1 ]
Zhao, Zhuxiang [1 ]
Zhao, Ziwen [1 ]
机构
[1] South China Univ Technol, Affiliated Hosp 2, Dept Pulm & Crit Care Med, Guangzhou Peoples Hosp 1, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China
[2] South China Univ Technol, Affiliated Hosp 2, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
lncRNA MALAT1; miR-200a-3p; NSCLC; PD-L1; LONG NONCODING RNA; PROLIFERATION; PD-L1; IMMUNOTHERAPY; EXPRESSION; PATHWAY;
D O I
10.1177/2058738419859699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study was to investigate the expression correlation between long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1), miR-200a-3p and programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), and their roles in NSCLC. Real-time polymerase chain reaction (PCR) was performed to detect the expressions of MALAT1, miR-200a-3p and PD-L1 in NSCLC tissues and cells for the correlation analysis. The starBase and Targetscan databases were used to predict the binding sites between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1, respectively. The targeting relationship between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1 were further verified by real-time PCR and dual luciferase reporter gene assay. Cell proliferation was monitored by CCK8 and colony formation assays. The apoptosis was detected using flow cytometry. Wound healing assay and transwell assay were conducted to determine cell migration and invasion. In this study, we demonstrated that in NSCLC tissues, the expression level of MALAT1 was negatively correlated with that of miR-200a-3p, while positively correlated with PD-L1. Besides, MALAT1 promoted proliferation, mobility, migration, and invasion of NSCLC cells via sponging miR-200a-3p. PD-L1 was validated as a target of miR-200a-3p, and indirectly modulated by MALAT1. In conclusion, LncRNA MALAT1 facilitates the progression of NSCLC by modulating miR-200a-3p/PDL1 axis.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Heterogeneity and prognosis of programmed cell death-ligand 1 expression in the circulating tumor cells of non-small cell lung cancer
    Wang, He-Lin
    Wu, Jie-Qing
    Wang, Ying
    Yu, Jian
    Mao, Xiao-Na
    Li, Zhuo-Ran
    Niu, Hong-Rui
    Jin, Cai-Ling
    Wang, Xiao-Jue
    Yan, Zhuo-Hong
    Yi, Ling
    Yang, Bin
    Wei, Pan-Jian
    Zhang, Hong-Tao
    Zhang, Shu-Cai
    NEOPLASMA, 2021, 68 (04) : 823 - 831
  • [22] Programmed death ligand-1 expression in non-small cell lung cancer
    Velcheti, Vamsidhar
    Schalper, Kurt A.
    Carvajal, Daniel E.
    Anagnostou, Valsamo K.
    Syrigos, Konstantinos N.
    Sznol, Mario
    Herbst, Roy S.
    Gettinger, Scott N.
    Chen, Lieping
    Rimm, David L.
    LABORATORY INVESTIGATION, 2014, 94 (01) : 107 - 116
  • [23] Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis
    Sun, Rongguo
    Zhang, Liang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 1036 - 1045
  • [24] Programmed Cell Death Ligand 1 Expression in Resected Non-Small Cell Lung Cancer
    Yu, Hui
    Brustugun, Odd Terje
    Ekman, Simon
    Botling, Johan
    La Fleur, Linnea
    Micke, Patrick
    Solberg, Steinar
    Berglund, Anders
    Rivard, Christopher
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2021, 22 (04) : E555 - E562
  • [25] Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-small cell lung cancer
    Villaruz, Liza C.
    Blumenschein Jr, George R.
    Otterson, Gregory A.
    Leal, Ticiana A.
    CANCER, 2023, 129 (09) : 1319 - 1350
  • [26] paper Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer
    Hisakane, Kakeru
    Seike, Masahiro
    Sugano, Teppei
    Matsuda, Kuniko
    Kashiwada, Takeru
    Nakamichi, Shinji
    Matsumoto, Masaru
    Miyanaga, Akihiko
    Noro, Rintaro
    Kubota, Kaoru
    Gemma, Akihiko
    GENE, 2023, 857
  • [27] Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer
    Chen, Jingyi
    Chen, Yusong
    Feng, Fenglan
    Chen, Cheng
    Zeng, Haikang
    Wen, Shuai
    Xu, Xin
    He, Jianxing
    Li, Jin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6711 - +
  • [28] LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis
    Ying Zhang
    Fuyou Wang
    Guangxing Chen
    Rui He
    Liu Yang
    Cell & Bioscience, 9
  • [29] LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis
    Zhang, Ying
    Wang, Fuyou
    Chen, Guangxing
    He, Rui
    Yang, Liu
    CELL AND BIOSCIENCE, 2019, 9 (1):
  • [30] Immunohistochemical Expression of Programmed Death-Ligand 1 in Diabetic Patients vs Non-Diabetics with Non-Small Cell Lung Cancer
    Zaleski, M.
    Sharzehi, S.
    Voland, R.
    Varlotto, J.
    Rassaei, N.
    Liu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S949 - S949